Variant report
Variant | nsv982328 |
---|---|
Chromosome Location | chr9:101369419-101371615 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:101259976..101262870-chr9:101371047..101374046,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs550639213 | chr9:101369419-101369420 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs113493231 | chr9:101369422-101369423 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs11538080 | chr9:101369454-101369455 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs573016760 | chr9:101369559-101369560 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs541931662 | chr9:101369563-101369564 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs77545309 | chr9:101369568-101369569 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs575370595 | chr9:101369586-101369587 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544360048 | chr9:101369595-101369596 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs142340869 | chr9:101369638-101369639 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs533009474 | chr9:101369639-101369640 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs151250762 | chr9:101369654-101369655 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs183454882 | chr9:101369672-101369673 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs529378130 | chr9:101369701-101369702 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs187573541 | chr9:101369718-101369719 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs569302428 | chr9:101369776-101369777 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs74326515 | chr9:101369792-101369793 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs74498704 | chr9:101369858-101369859 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs190962050 | chr9:101369862-101369863 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534488336 | chr9:101369967-101369968 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs571241936 | chr9:101369985-101369986 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571173714 | chr9:101370006-101370007 | Enhancers Active TSS Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs182114036 | chr9:101370112-101370113 | Enhancers Active TSS Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558728102 | chr9:101370142-101370143 | Enhancers Active TSS Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs374674625 | chr9:101370153-101370154 | Enhancers Active TSS Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs149751478 | chr9:101370211-101370212 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs186755922 | chr9:101370271-101370272 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs146745959 | chr9:101370275-101370276 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs12377101 | chr9:101370349-101370350 | Enhancers Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs140390639 | chr9:101370350-101370351 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs533742635 | chr9:101370373-101370374 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs563068609 | chr9:101370382-101370383 | Enhancers Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs145486426 | chr9:101370406-101370407 | Enhancers Active TSS Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs540117858 | chr9:101370429-101370430 | Enhancers Active TSS Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs559990017 | chr9:101370438-101370439 | Enhancers Active TSS Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs573716337 | chr9:101370439-101370440 | Enhancers Active TSS Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs146485822 | chr9:101370446-101370447 | Enhancers Active TSS Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs149070759 | chr9:101370464-101370465 | Enhancers Active TSS Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192659532 | chr9:101370486-101370487 | Enhancers Active TSS Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs542260499 | chr9:101370586-101370587 | Enhancers Active TSS Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs143056527 | chr9:101370592-101370593 | Enhancers Active TSS Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs148193640 | chr9:101370600-101370601 | Enhancers Weak transcription Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs560532587 | chr9:101370604-101370605 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs553303259 | chr9:101370608-101370609 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs111678325 | chr9:101370638-101370639 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs567924548 | chr9:101370694-101370695 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs535452185 | chr9:101370705-101370706 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs548916100 | chr9:101370739-101370740 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs565345722 | chr9:101370741-101370742 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs568904451 | chr9:101370770-101370771 | Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs185046110 | chr9:101370835-101370836 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Biliary cancer | 19435499 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Breast cancer | 17133270 | CNVD |
Basal cell nevus syndrome | 21572526 | CNVD |
Mental retardation | 19951919 | CNVD |
Retinoblastoma | 22278416 | CNVD |
9q22.3 microdeletion syndrome | 22283845 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
overgrowth syndrome | 16570072 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Nicotine dependence | 17160897 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Melanoma | 17363583 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:101364400-101371600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr9:101365400-101386800 | Weak transcription | Brain Angular Gyrus | brain |
3 | chr9:101368800-101370000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
4 | chr9:101369200-101370000 | Enhancers | HUVEC | blood vessel |
5 | chr9:101369400-101370000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr9:101369600-101370600 | Enhancers | NHLF | lung |
7 | chr9:101369800-101370200 | Enhancers | Osteobl | bone |
8 | chr9:101370000-101370200 | Flanking Active TSS | HUVEC | blood vessel |
9 | chr9:101370000-101370600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
10 | chr9:101370000-101370600 | Active TSS | IMR90 fetal lung fibroblasts Cell Line | lung |
11 | chr9:101370000-101370600 | Enhancers | NH-A | brain |
12 | chr9:101370200-101370400 | Enhancers | HUVEC | blood vessel |
13 | chr9:101370400-101370600 | Enhancers | Fetal Lung | lung |
14 | chr9:101370400-101370800 | Flanking Active TSS | HUVEC | blood vessel |
15 | chr9:101370600-101371400 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
16 | chr9:101370600-101372400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
17 | chr9:101370600-101372600 | Weak transcription | NH-A | brain |
18 | chr9:101370800-101371800 | Weak transcription | Fetal Lung | lung |
19 | chr9:101370800-101373600 | Enhancers | HUVEC | blood vessel |
20 | chr9:101371400-101375400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
21 | chr9:101371600-101371800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |